FDA MedWatch Recall Notice - Hellolife Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination

If your email program has trouble displaying this email, view it as a web page
 
U.S. Food and Drug Administration Header

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

A new MedWatch Safety Alert recall: Hellolife, Inc. Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination was just added to the FDA Recalls webpage.
 
You can read the complete recall alert at: https://www.fda.gov/Safety/Recalls/ucm618926.htm
 
 

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists

Comments

Popular Posts

Fwd: Claim "Climate law & governance" for your profile

Commissions Successfully

Beneficiary countersignature modification

Your order requires immediate confirmation.

Reduced Payment!.

You’re four weeks away from more followers 📱

The State Department requires proof that you are the owner.

January 3nd Nоte (Оpen Up)

We have Your e-Wallet ready. Claim in 3hrs